TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 132 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $128,000 | +0.8% | 1,134 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $127,000 | -3.8% | 1,134 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $132,000 | +10.9% | 1,134 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $119,000 | -4.8% | 1,134 | 0.0% | 0.01% | -11.1% |
| Q3 2016 | $125,000 | -38.4% | 1,134 | -18.7% | 0.01% | -35.7% |
| Q2 2016 | $203,000 | +1.5% | 1,394 | 0.0% | 0.01% | -6.7% |
| Q1 2016 | $200,000 | – | 1,394 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 78,905 | $8,306,000 | 7.65% |
| FORT, L.P. | 157,584 | $16,589,000 | 4.68% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 808,200 | $85,079,000 | 4.39% |
| Strategic Global Advisors, LLC | 81,432 | $8,572,000 | 3.18% |
| Prince Street Capital Management LLC | 48,700 | $5,127,000 | 1.62% |
| Analyst IMS Investment Management Services Ltd. | 31,438 | $3,309,000 | 1.45% |
| Freestone Capital Holdings, LLC | 84,900 | $8,937,000 | 0.77% |
| RPG Investment Advisory, LLC | 17,227 | $1,813,000 | 0.61% |
| CLINTON GROUP INC | 46,370 | $4,881,000 | 0.28% |
| USA FINANCIAL FORMULAS | 10,786 | $1,135,000 | 0.28% |